Loading...

Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population

OBJECTIVE: Pivotal trial have shown that patients with multiple sclerosis (MS) receiving ocrelizumab had better outcomes. However, data on ocrelizumab in clinical practice are limited. The aim of this study was to evaluate the preliminary safety profile and effectiveness of ocrelizumab treatment for...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ann Clin Transl Neurol
Main Authors: Fernandez‐Diaz, Eva, Perez‐Vicente, Jose A., Villaverde‐Gonzalez, Ramon, Berenguer‐Ruiz, Leticia, Candeliere Merlicco, Antonio, Martinez‐Navarro, Maria Luisa, Gracia Gil, Julia, Romero‐Sanchez, Carlos M., Alfaro‐Saez, Arantxa, Diaz, Inmaculada, Gimenez‐Martinez, Juana, Mendez‐Miralles, Maria Angeles, Millan‐Pascual, Jorge, Jimenez‐Pancho, Javier, Mola, Santiago, Sempere, Angel P.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7886031/
https://ncbi.nlm.nih.gov/pubmed/33369288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51282
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!